|Bid||13.65 x 1000|
|Ask||14.50 x 800|
|Day's Range||13.97 - 15.11|
|52 Week Range||13.97 - 42.57|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||36.33|
Insiders who bought US$184k worth of Sight Sciences, Inc. ( NASDAQ:SGHT ) stock in the last year have seen some of...
In this segment of Backstage Pass, recorded on Dec. 13, 2021, Fool contributor Asit Sharma discusses a newly public healthcare stock that long-term investors may want to put on their radar right now. Asit Sharma: What is Sight Sciences (NASDAQ: SGHT)? This is a company founded in 2011 by two brothers, David and Paul Badawi.
Sight Sciences (NASDAQ: SGHT) only recently made its public debut. Since the company's initial public offering last summer, shares have plunged by nearly 50%. Is this company, which markets medical devices to treat diseases of the eye, one that investors should put on their watch list right now?